Tislelizumab: The Backbone of Future Immunotherapy Combinations

 VIDEO   00:14:28   10/2021

BeiGene - Tislelizumab: The Backbone of Future Immunotherapy Combinations

Sunday, September 19, 2021 | 10:30–12:00 (CEST)

 

Riyaz Shah
Consultant Medical Oncologist
Maidstone and Tunbridge Wells Hospitals Kent, UK

Rating

Rate this resource